Advertisement

Topics

Biogen Inc.

02:08 EDT 21 Aug 2017 | Topix

The brokerage presently has a $338.00 price target on the biotechnology company's stock. Goldman Sachs Group, Inc. 's price objective points to a potential upside of 19.96% from the company's previous close.

Original Article: Biogen Inc.

NEXT ARTICLE

More From BioPortfolio on "Biogen Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...